Boardroom Alpha
Meeting calendar
GBTG · Annual meeting · Wednesday, May 13, 2026

Global Business Travel Group Inc

3 nominees · 5 ballot items.

Election of three Class I directors; ratification of KPMG LLP as independent auditors; advisory approval of named executive officer compensation (say-on-pay); approval of an amendment to the 2022 Equity Incentive Plan to increase the share reserve by 70.5 million shares; and any other matter properly coming before the meeting.

Market cap
$4.9B
1Y TSR
+45.1%
Board grade
C+
Record date
Mar 17, 2026
Filing
DEF 14A
Meeting concluded · May 13, 2026

Follow how the vote landed and what changed on Global Business Travel Group Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot5

  1. 1

    Election of Directors (Class I

    ManagementBoard: FOR

    Elect three Class I directors — Paul Abbott, Eric Hart, and Kathleen Winters — each for a three-year term expiring at the 2029 annual meeting.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm (KPMG LLP

    ManagementBoard: FOR

    Ratify the Audit and Finance Committee’s selection of KPMG LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.

  3. 3

    Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement (say-on-pay).

    More detail

    This proposal asks stockholders to cast a non-binding advisory vote approving the compensation of the Company’s named executive officers as disclosed in the proxy statement. Management seeks this advisory endorsement to validate its pay philosophy and to demonstrate alignment between executive incentives and the Company’s strategic and financial goals, including multi-year PSUs tied to Adjusted EBITDA and cash generation metrics. The Compensation Committee emphasizes a pay-for-performance mix with a significant portion of compensation at risk, including RSUs for retention and PSUs with a relative TSR modifier to align long-term pay with shareholder returns. The Board frames the say-on-pay vote as an important governance feedback mechanism; although advisory, the Committee states it will consider the vote outcome when setting future compensation policies. Key contextual factors include the Company’s 2025 performance (Adjusted EBITDA growth, revenue growth, acquisition of CWT and identified synergies) and recent practice of linking annual incentives to a mix of financial, customer and colleague metrics. Management also highlights governance features intended to mitigate risk, such as clawback policies, minimum vesting, and prohibitions on hedging/pledging. The Board’s recommendation rationale is that the executive program appropriately balances retention, long-term performance incentives, and risk controls, and that stockholder approval would endorse these governance and pay structures.

  4. 4

    Approval of Amendment to the 2022 Equity Incentive Plan

    ManagementBoard: FOR

    Approve the amendment to the 2022 Equity Incentive Plan to increase the share reserve by 70.5 million shares and make related plan changes (the "Amended Plan").

    More detail

    This management proposal seeks shareholder approval to increase the authorized share reserve under the Company’s 2022 Equity Incentive Plan by 70.5 million shares and to affirm related plan provisions enabling equity awards to employees, consultants and non-employee directors. Management and the Compensation Committee argue the increase is necessary because the existing reserve is insufficient to support the Company’s expected long‑term grant needs, particularly given recent strategic activity (including the CWT acquisition), growth in headcount and ongoing retention and performance programs. The Amended Plan would preserve standard governance features: administration by the independent Compensation Committee, limits on director awards, recoupment/clawback provisions, and customary anti-dilution and change-in-control adjustment mechanisms. The proposal also seeks to ensure compliance with NYSE rules and to permit grants of incentive stock options where applicable. From a governance perspective, the Board emphasizes that the requested reserve is intended to sustain current grant practices (RSUs and PSUs) that link a substantial portion of pay to multi-year Adjusted EBITDA and cash-flow performance metrics and to include relative TSR modifiers on PSUs, thereby aligning long-term executive pay with shareholder outcomes. Economically, shareholders should expect dilution from the additional shares; the Board considered burn rate, share usage, volatility, and dilution in setting the requested amount and states the increase is expected to cover awards for approximately five years under current assumptions. The Board’s recommendation rationale is that maintaining an adequate equity reserve is required to execute compensation strategy, retain critical talent during integration and growth, and continue incentivizing performance aligned with shareholder interests, while retaining committee discretion and customary safeguards to mitigate undue dilution.

  5. 5

    Other Matters That May Properly Come Before the Annual Meeting

    Management

    Consideration of any other matters that properly come before the Annual Meeting, to be voted on at the discretion of the proxy holders if presented.

    More detail

    This is a catch-all, procedural item reserved for any additional, unforeseen matters properly presented at the meeting that were not specifically described in the proxy materials. The proxy materials authorize the named proxy holders to vote in their discretion on such matters, and the Board notes it knows of no other items expected to be presented. From a governance perspective, this item offers flexibility to address housekeeping items or routine matters that may arise prior to or at the meeting, but it does not represent a substantive standalone policy change or corporate action. Because the item is undefined in advance, stockholders cannot meaningfully evaluate potential outcomes today; the legal and voting consequences therefore depend entirely on the specific matter, the required vote standard, and the information provided at the time of presentation. Historically, such matters are typically routine and non-controversial (e.g., adjournment motions, procedural ratifications), and brokers may exercise discretion on truly routine matters where allowed. The Board does not provide a specific recommendation for this open item; proxies submitted without direction generally authorize the named proxies to vote as they deem appropriate. Stockholders who wish to influence any such unforeseen matter should attend the virtual meeting or provide specific voting instructions to their broker or nominee where permitted.

Director elections

Nominees on the ballot3

Not independent
Tenure on this board
4.1 yrs
Also a director at
Trivago NV (TRVG)
Independent
Tenure on this board
4.1 yrs
Also a director at
Definitive Healthcare Corp (DH)Hartford Insurance Group Inc (HIG)
Ownership

Top institutional holders10

Latest 13F quarter
1AMERICAN EXPRESS CO30.3%157,786,199$880M
2BlackRock, Inc.7.5%38,973,092$217M
3Apollo Management Holdings, L.P.4.4%22,884,991$128M
4REDWOOD CAPITAL MANAGEMENT, LLC4.2%21,953,816$123M
5ARES MANAGEMENT LLC2.7%13,886,023$77M
6Attestor Capital Ltd1.7%8,878,004$49M
7Monarch Alternative Capital LP1.5%7,800,000$44M
8VANGUARD CAPITAL MANAGEMENT LLC1.3%6,582,303$37M
9VANGUARD PORTFOLIO MANAGEMENT LLC1.2%6,442,231$36M
10BlackRock, Inc.1.0%5,002,055$28M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Global Business Travel Group Inc 2026 annual meeting?
Global Business Travel Group Inc (GBTG) holds its 2026 annual shareholder meeting on Wednesday, May 13, 2026.
What is the record date for the Global Business Travel Group Inc 2026 meeting?
The record date for the Global Business Travel Group Inc 2026 meeting is Tuesday, March 17, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Global Business Travel Group Inc's 2026 meeting?
The board is presenting 3 director nominees at the Global Business Travel Group Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Global Business Travel Group Inc 2026 meeting?
Shareholders will vote on 5 proposals at the Global Business Travel Group Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer